Biomerica (BMRA) Cash from Financing Activities (2010 - 2026)
Biomerica (BMRA) reported Cash from Financing Activities of $61000.0 for Q1 2026, down 96.49% on a YoY basis from $1.7 million in Q1 2025, and down 87.34% sequentially from $482000.0 in Q4 2025.
Biomerica (BMRA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Cash from Financing Activities data on file, last reported at $61000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 96.49% year-over-year to $61000.0; the trailing twelve-month figure through Feb 2026 stood at $1.5 million (down 84.4% YoY), and the FY2025 full-year result was $2.1 million, up 2706.17% from the prior year.
- Cash from Financing Activities retreated to $61000.0 in Q1 2026, from $482000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $7.4 million in Q2 2023 to a low of -$5000.0 in Q2 2025.
- A 4-year average of $1.2 million and a median of $482000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 19414.14% in 2023 and tumbled 96.49% in 2026, its largest moves.
- Tracing BMRA's Cash from Financing Activities over 4 years: stood at $237000.0 in 2022, then jumped by 3001.27% to $7.4 million in 2023, then sank by 93.44% to $482000.0 in 2025, then slumped by 87.34% to $61000.0 in 2026.
- Business Quant data shows BMRA's Cash from Financing Activities at $61000.0 in Q1 2026, $482000.0 in Q4 2025, and $920000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 61,000.00 |
| Feb 28, 2026 | 61,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Aug 31, 2025 | 920,000.00 |
| Aug 31, 2025 | 920,000.00 |
| May 31, 2025 | -5,000.00 |
| May 31, 2025 | -5,000.00 |
| Feb 28, 2025 | 1.74 Mn |
| Feb 28, 2025 | 1.74 Mn |
| May 31, 2023 | 7.35 Mn |
| May 31, 2023 | 7.35 Mn |
| Feb 28, 2023 | 25,000.00 |
| Feb 28, 2023 | 25,000.00 |
| Nov 30, 2022 | 237,000.00 |
| Nov 30, 2022 | 237,000.00 |
| Aug 31, 2022 | 1.78 Mn |
| Aug 31, 2022 | 1.78 Mn |
| May 31, 2022 | 37,665.00 |
| May 31, 2022 | 37,665.00 |